Learn How to Pronounce palivizumab

Quick Answer: The International Nonproprietary Name palivizumab is pronounced /ˌpælɪˈvizʊmæb/.
(Listen to the audio above for the stress and intonation)

The Expert's Take

Dr. Franz Lang

"During a university health fair, I overheard two medical students practicing patient explanations for complex treatments. One struggled with the pronunciation of "palivizumab," tripping over the sequence of 'i' and 'z' sounds. It struck me as a perfect example of how specialized jargon creates its own phonetic landscape, one that healthcare professionals must navigate as fluently as they do the medicine itself."

By Dr. Franz Lang

Meaning and Context

Palivizumab is a humanized monoclonal antibody medication, marketed under the brand name Synagis, specifically engineered to provide passive immunity against the respiratory syncytial virus (RSV). Approved by the U.S. Food and Drug Administration (FDA) in 1998, it is not a treatment for active infection but a critical prophylactic agent administered as a monthly intramuscular injection during the RSV season. Its primary use is to prevent severe lower respiratory tract disease, such as bronchiolitis and pneumonia, in high-risk pediatric populations. This includes infants born prematurely (before 35 weeks gestation), children under two years of age with chronic lung disease like bronchopulmonary dysplasia (BPD), and those with significant congenital heart disease (CHD). The drug works by binding to the F (fusion) protein on the surface of RSV, inhibiting its ability to infect respiratory tract cells. The RSV prophylaxis guidelines from major pediatric health organizations strictly define the eligibility criteria for palivizumab injection, making it a cornerstone of preventive care for high-risk infants and a key component in reducing pediatric hospitalizations due to this common and potentially dangerous virus.

Common Mistakes and Alternative Spellings

The term "palivizumab" follows a standardized pharmaceutical nomenclature for monoclonal antibodies, with the suffix "-mab" indicating its classification. Common misspellings and typographical errors often arise from phonetic misinterpretation or simple keystroke mistakes. Frequent variants include "palivizimab" (substituting a 'z' for the 's' and incorrectly using 'i'), "palivisumab," and "pavilizumab" (transposing the 'l' and 'v'). Other errors are "palivuzimab" or the omission of the second 'i,' as in "palivzumab." In clinical notes, one might also encounter the brand name "Synagis" misspelled as "Synagis," "Synagus," or "Sinagis." It is crucial for medical professionals, pharmacists, and caregivers to use the precise spelling "palivizumab" to ensure accurate communication, proper prescription filling, and correct medical record-keeping, thereby avoiding potential medication errors.

Example Sentences

The neonatology team recommended a course of palivizumab for the premature infant to protect him during the upcoming RSV season.

According to the latest American Academy of Pediatrics guidelines, eligibility for palivizumab prophylaxis is now more restricted than in previous years.

Each monthly dose of palivizumab must be timed precisely to maintain adequate antibody levels in the child's bloodstream.

While costly, the administration of palivizumab has been shown to be cost-effective for certain high-risk groups by significantly reducing the rate of ICU admissions.

The pediatrician explained that palivizumab is not a vaccine but provides temporary, immediate protection against severe RSV disease.

Parents of a child with hemodynamically significant congenital heart disease should discuss the benefits of palivizumab with their cardiologist well before the fall months.

Sources and References

I consulted the medical monograph on Drugs.com and the entry on Wikipedia. I also used Forvo to hear a spoken example. Additionally, I found educational videos for healthcare professionals on platforms like Medscape and YouTube, where the drug name is pronounced in medical lectures.

Related Pronunciations

📂 Browse all words in the Drugs, Molecules and Vaccines category ➔